Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

During the Trading Day
69.48 +0.68 / +0.99%
As of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
69.48 0.00 / 0.00%
 
Volume: 13.1K

Today’s Trading

Previous close68.80
Today’s open69.22
Day’s range68.83 - 71.42
Volume2,830,199
Average volume (3 months)3,027,966
Market cap$7.7B
Dividend yield--
Data as of 4:02pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+6.28%
Earnings growth (next 5 years)+9.10%
Revenue growth (last year)+31.75%
P/E ratio26.6
Price/Sales2.40
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-3.10-2.48%
RDYDr.Reddy's Laborator...+0.30+0.67%
IDXXIDEXX Laboratories I...+0.12+0.17%
TAROTaro Pharmaceutical ...+0.56+0.40%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$1.77
Annual revenue (last year)$3.3B
Annual profit (last year)$322.1M
Net profit margin9.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts

Partner Offers